ID

21439

Descripción

Acute Promyelocytic Leukemia 2006 (APL); ODM derived from: https://clinicaltrials.gov/show/NCT00378365

Link

https://clinicaltrials.gov/show/NCT00378365

Palabras clave

Versiones (2)
  1. 21/4/17 21/4/17 -
  2. 21/4/17 21/4/17 -
Subido en

21 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

Inglés

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of apl based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or pml-rara rearrangement with characterization of the bcr subtype (pml-rar characterization).
Descripción

Acute Promyelocytic Leukemia | t(15;17)(q22;q12) | t(15;17)(PML,RARA) | PML-RARa bcr1 fusion protein, human

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023487
UMLS CUI [2]
C1515724
UMLS CUI [3]
C1979990
UMLS CUI [4]
C3493223
untreated patients.
Descripción

Patients Untreated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
no contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
Descripción

Chemotherapy intense Medical contraindication Absent | Idarubicin Medical contraindication cardiac Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0522510
UMLS CUI [1,3]
C1301624
UMLS CUI [1,4]
C0332197
UMLS CUI [2,1]
C0020789
UMLS CUI [2,2]
C1301624
UMLS CUI [2,3]
C0018787
UMLS CUI [2,4]
C0332197
in female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of atra in early pregnancy).
Descripción

Gender Contraceptive methods | Pregnancy Absent | Tretinoin | Teratogenic effects Pregnancy Early

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0040845
UMLS CUI [4,1]
C0232910
UMLS CUI [4,2]
C0032961
UMLS CUI [4,3]
C1279919
absence of hypersensitivity to arsenic derivatives.
Descripción

Arsenic derivatives Hypersensitivity Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003818
UMLS CUI [1,2]
C0243072
UMLS CUI [1,3]
C0020517
UMLS CUI [1,4]
C0332197
no qt interval prolongation or complete atria-ventricular block.
Descripción

Prolonged QT interval Absent | Complete atrioventricular block Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0151878
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0151517
UMLS CUI [2,2]
C0332197
written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients already treated.
Descripción

Patients Treated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522326
patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to idarubicin.
Descripción

Medical contraindication Chemotherapy intense | Medical contraindication cardiac Idarubicin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0522510
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0018787
UMLS CUI [2,3]
C0020789
in female patients: pregnancy or absence of adequate contraceptive methods
Descripción

Pregnancy | Gender Contraceptive methods Absent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332197
qt interval prolongation or complete atria-ventricular block.
Descripción

Prolonged QT interval | Complete atrioventricular block

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151878
UMLS CUI [2]
C0151517
hypersensitivity to arsenic derivatives.
Descripción

Hypersensitivity Arsenic derivatives

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003818
UMLS CUI [1,3]
C0243072
Volver a la parte superior de la página

Similar models

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Acute Promyelocytic Leukemia | t(15;17)(q22;q12) | t(15;17)(PML,RARA) | PML-RARa bcr1 fusion protein, human
Item
diagnosis of apl based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or pml-rara rearrangement with characterization of the bcr subtype (pml-rar characterization).
boolean
C0023487 (UMLS CUI [1])
C1515724 (UMLS CUI [2])
C1979990 (UMLS CUI [3])
C3493223 (UMLS CUI [4])
Patients Untreated
Item
untreated patients.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Chemotherapy intense Medical contraindication Absent | Idarubicin Medical contraindication cardiac Absent
Item
no contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
boolean
C0392920 (UMLS CUI [1,1])
C0522510 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
C0020789 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0018787 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
Gender Contraceptive methods | Pregnancy Absent | Tretinoin | Teratogenic effects Pregnancy Early
Item
in female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of atra in early pregnancy).
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0040845 (UMLS CUI [3])
C0232910 (UMLS CUI [4,1])
C0032961 (UMLS CUI [4,2])
C1279919 (UMLS CUI [4,3])
Arsenic derivatives Hypersensitivity Absent
Item
absence of hypersensitivity to arsenic derivatives.
boolean
C0003818 (UMLS CUI [1,1])
C0243072 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Prolonged QT interval Absent | Complete atrioventricular block Absent
Item
no qt interval prolongation or complete atria-ventricular block.
boolean
C0151878 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0151517 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patients Treated
Item
patients already treated.
boolean
C0030705 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
Medical contraindication Chemotherapy intense | Medical contraindication cardiac Idarubicin
Item
patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to idarubicin.
boolean
C1301624 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0522510 (UMLS CUI [1,3])
C1301624 (UMLS CUI [2,1])
C0018787 (UMLS CUI [2,2])
C0020789 (UMLS CUI [2,3])
Pregnancy | Gender Contraceptive methods Absent
Item
in female patients: pregnancy or absence of adequate contraceptive methods
boolean
C0032961 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Prolonged QT interval | Complete atrioventricular block
Item
qt interval prolongation or complete atria-ventricular block.
boolean
C0151878 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
Hypersensitivity Arsenic derivatives
Item
hypersensitivity to arsenic derivatives.
boolean
C0020517 (UMLS CUI [1,1])
C0003818 (UMLS CUI [1,2])
C0243072 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial